Gregg Katz, a partner in Goodwin’s Technology Companies Group, works on a wide variety of public and private securities offerings, mergers and acquisitions and other complex transactions. His practice centers on technology companies, including clients in the software, hardware, biotechnology, pharmaceuticals and other technology-driven industries.

Mr. Katz’ representation of start-up and later-stage companies spans the entire corporate lifecycle, including pre-incorporation planning, venture capital financings, public offerings, SEC reporting and disclosure, mergers and acquisitions, and general corporate representation and counseling.

Experience

ERFAHRUNG

工作经历

Mr. Katz’ transactional experience includes representing: 

Public Offerings - Issuer

  • Bluebird bio, a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, in its $116 million initial public offering on NASDAQ and in five follow-on public offerings totaling $1.6 billion  
  • Aquaventure Holdings, a multinational provider of water-as-a-service solutions, in its $135 million initial public offering on NYSE
  • Alnylam Pharmaceuticals, a leading RNAi therapeutics company, in two follow-on public offerings totaling $877 million
  • Eloqua, a provider of on-demand revenue performance management software solutions, in its $106 million initial public offering on NASDAQ
  • Omthera Pharmaceuticals, a pharmaceutical company focused on therapies for abnormalities in blood lipids and the treatment of cardiovascular disease, in its $64 million initial public offering on NASDAQ

Public Offerings - Underwriter

  • Goldman Sachs and Morgan Stanley in the $300 million initial public offering of Blue Apron on NYSE
  • Goldman Sachs, Credit Suisse and Bank of America in the $113 million initial public offering of Alarm.com on NASDAQ
  • Goldman Sachs and Deutsche Bank in the $235 million and $344 million follow-on public offerings of CyberArk Software
  • J.P. Morgan and Deutsche Bank in the $99 million initial public offering of CyberArk Software on NASDAQ 
  • Goldman Sachs and Credit Suisse in the $133 million initial public offering of 2U on NASDAQ and in two follow-on offerings totaling $343 million
  • Stifel in the $57 million initial public offering of SPS Commerce on NASDAQ and in four follow-on offerings totaling $172 million

Private Financings

  • Toast, a provider of restaurant point-of-sale and management systems, in its Series B and Series C financings
  • Salsify, a product content management platform for distributed commerce, in its Series A, Series B and Series C financings
  • Circle Internet Financial, a digital currency company, in its Series A, Series B, Series C and Series D financings
  • Alnylam Pharmaceuticals, a leading RNAi therapeutics company, in a $700 million equity financing closed in connection with Alnylam’s collaboration with Genzyme
  • Carrick Therapeutics, a European oncology company, in its initial funding round
  • Genomics Medicine Ireland, an Irish genomics research company, in its Series A financing
  • TellusLabs, a satellite imagery and machine learning company, in its seed financing
  • Innophase, an innovative semiconductor company, in its Series B financing
  • Infinio Systems, a leader in storage acceleration for virtualized data centers, in its Series B financing
  • Bedford Funding in its Series C investment in Voalte and Series D investment in MDLIVE

Mergers & Acquisitions

  • Teva Pharmaceutical Industries, a leading global pharmaceutical company, in the sale of its specialty women’s global health business
  • iRobot Corporation, a leading global consumer robot company in its acquisitions of Robopolis SAS and Evolution Robotics and in the sale of its Defense & Security business to Arlington Capital Partners
  • Code42 Software, a leader in cloud-based endpoint data protection and recovery, in the sale of its consumer business to Carbonite
  • Plex Systems, a leader in cloud ERP for manufacturing, in its acquisition of DemandCaster
  • Epidemico, an informatics company providing early insights, continuous monitoring and consumer engagement for varied aspects of population health, in its sale to Booz Allen Hamilton
  • bluebird bio in its acquisition of Precision Genome Engineering
  • Eloqua, a leading provider of on-demand revenue performance management software solutions, in its sale to Oracle Corporation
  • Endeca Technologies, a provider of unstructured data management, web commerce and business intelligence solutions, in its sale to Oracle Corporation
  • Attend, an event software company, in its sale to Event Farm
  • WaveMark, a provider of real-time healthcare supply chain solutions, in its sale to Cardinal Health
Professional Activities

Mr. Katz is a member of the Massachusetts and Boston Bar Associations. He also serves on the board of directors of the Hillel Council of New England.

Recognition

While attending law school, Mr. Katz was the articles editor of the Boston College Law Review, for which he authored "Conflicting Fiduciary Duties Within Collegiate Athletic Conferences: A Prescription for Leniency."

In The News

MELDUNGEN

在新闻中

Credentials

WERDEGANG

专业资格

Education

J.D., 2006
Boston College Law School

(magna cum laude, Order of the Coif)

A.B., 2001
Duke University

(magna cum laude)

Admissions

Bar

Massachusetts
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
搜寻其他律师